ZA744243B - Pharmaceutical tablet - Google Patents

Pharmaceutical tablet

Info

Publication number
ZA744243B
ZA744243B ZA00744243A ZA744243A ZA744243B ZA 744243 B ZA744243 B ZA 744243B ZA 00744243 A ZA00744243 A ZA 00744243A ZA 744243 A ZA744243 A ZA 744243A ZA 744243 B ZA744243 B ZA 744243B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical tablet
tablet
pharmaceutical
Prior art date
Application number
ZA00744243A
Other languages
English (en)
Inventor
D Scharland
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of ZA744243B publication Critical patent/ZA744243B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA00744243A 1973-07-12 1974-07-02 Pharmaceutical tablet ZA744243B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3321473A GB1466857A (en) 1973-07-12 1973-07-12 Urea tablets

Publications (1)

Publication Number Publication Date
ZA744243B true ZA744243B (en) 1975-06-25

Family

ID=10350041

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00744243A ZA744243B (en) 1973-07-12 1974-07-02 Pharmaceutical tablet

Country Status (12)

Country Link
US (1) US3996365A (sv)
JP (1) JPS5714650B2 (sv)
BE (1) BE817515A (sv)
CA (1) CA1039653A (sv)
DE (1) DE2433424A1 (sv)
DK (1) DK146843C (sv)
FR (1) FR2236485B1 (sv)
GB (1) GB1466857A (sv)
IE (1) IE39557B1 (sv)
NL (1) NL178563C (sv)
SE (1) SE392037B (sv)
ZA (1) ZA744243B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007002924A1 (de) 2007-01-19 2008-07-24 Bayer Healthcare Ag ß-Lactam-haltige Formulierungen mit erhöhter Stabilität in wässriger Lösung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679801A (en) * 1970-05-19 1972-07-25 Pfizer Aryl esters of {60 -carboxyarylmethyl-penicillins

Also Published As

Publication number Publication date
DK374674A (sv) 1975-03-03
DE2433424A1 (de) 1975-01-30
NL178563B (nl) 1985-11-18
DK146843B (da) 1984-01-23
SE7409100L (sv) 1975-01-13
DK146843C (da) 1984-07-16
NL7408986A (nl) 1975-01-14
US3996365A (en) 1976-12-07
JPS5714650B2 (sv) 1982-03-25
NL178563C (nl) 1986-04-16
AU7113574A (en) 1976-01-15
IE39557B1 (en) 1978-11-08
GB1466857A (en) 1977-03-09
FR2236485A1 (sv) 1975-02-07
JPS5031025A (sv) 1975-03-27
SE392037B (sv) 1977-03-14
BE817515A (fr) 1975-01-10
CA1039653A (en) 1978-10-03
IE39557L (en) 1975-01-12
FR2236485B1 (sv) 1978-07-21

Similar Documents

Publication Publication Date Title
AU7259274A (en) Medicaments
ZA731808B (en) Pharmaceutical compositions
AU6592274A (en) Capsules
HK41078A (en) Pharmaceutical composition
IL44646A0 (en) Novel pharmaceutical tablets
PH10938A (en) Solid ophthalmic medicinal product
HK72578A (en) Pharmaceutical compositions
AU7201374A (en) Pharmaceutical compositions
ZA7461B (en) Pharmaceutical formulation
AU6980774A (en) Capsules
HK1378A (en) Tablet formulation
ZA731012B (en) Pharmaceutical compositions
AU7194974A (en) Pharmaceutical product
ZA732439B (en) Pharmaceutical composition
HK57578A (en) Pharmaceutical compositions
CA940452A (en) Pharmaceutical tablet
ZA744243B (en) Pharmaceutical tablet
IL46223A0 (en) Drug interaction system
AU6595174A (en) Capsules
ZA728553B (en) Tablets
ZA742528B (en) Pharmaceutical tablets
AU7274074A (en) Drug
ZA734331B (en) Pharmaceutical compositions
AU480426B2 (en) Pharmaceutical tablets
HK53780A (en) Pharmaceutical preparations